2Andrzej C.Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of low molecular weight heparin gynecological ward retrosoective analysis. Eur J Obstet&Gynecol Reprod Biol . 2002
3Girard P,Sanchez O,Leroyer C,et al.Deep venous thrombosis in patients with acute pulmonary embolism:prevalence,risk factors,and clinical significance. Chest . 2005
4Girard P,Tardy B,Decousus H,et al.Inferior vena cava interruption: how and when. Annual Review of Medicine . 2000
5Geerts WH,Pineo GF,Heit JA,Bergqvist D,Lassen MR,Colwell CW,Ray JG.Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest . 2004
6Roussi J,Houbouyan L,Tere C,et al.Prophylactic and therapeutic use of a low molecular weight heparin fraction, CY 216. Journal des Maladies Vasculaires . 1987
7Busuttil RW,Tanaka K. The utility of marginal donors in liver transplantation[J].{H}Liver Transplantation,2003,(07):651-663.
8Cabrera AG,Prodhan P,Cleves MA. Interhospital transport of children requiring extracorporeal membrane oxygenation support for cardiac dysfunction[J].Congenit Heart Dis,2011,(03):202-208.
9Abt PL,Fisher CA,Singhal AK. Donation after cardiac death in the US:history and use[J].{H}Journal of the American College of Surgeons,2006,(02):208-225.
10Sánchez-Fructuoso AI,Prats D,Torrente J. Renal transplantation from non-heart beating donors:a promising alternative to enlarge the donor pool[J].{H}Journal of the American Society of Nephrology,2000,(02):350-358.
